David Helmreich - Innovid Corp Chief Officer
| CTVDelisted Stock | USD 3.14 0.00 0.00% |
Executive
David Helmreich is Chief Officer of Innovid Corp
| Age | 53 |
| Phone | 212 966 7555 |
| Web | https://www.innovid.com |
David Helmreich Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Helmreich against Innovid Corp stock is an integral part of due diligence when investing in Innovid Corp. David Helmreich insider activity provides valuable insight into whether Innovid Corp is net buyers or sellers over its current business cycle. Note, Innovid Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Innovid Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Helmreich over three months ago Acquisition by David Helmreich of 50000 shares of Innovid Corp at 1.0895 subject to Rule 16b-3 | ||
David Helmreich over three months ago Acquisition by David Helmreich of 50000 shares of Innovid Corp at 1.0895 subject to Rule 16b-3 |
Innovid Corp Management Efficiency
The company has Return on Asset of (0.0257) % which means that on every $100 spent on assets, it lost $0.0257. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0702) %, meaning that it generated no profit with money invested by stockholders. Innovid Corp's management efficiency ratios could be used to measure how well Innovid Corp manages its routine affairs as well as how well it operates its assets and liabilities.Innovid Corp has 21.83 M in debt with debt to equity (D/E) ratio of 0.09, which may show that the company is not taking advantage of profits from borrowing. Innovid Corp has a current ratio of 2.64, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Innovid to invest in growth at high rates of return.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jennie Kerr | Comtech Telecommunications Corp | N/A | |
| Hiran Bhadra | Belden Inc | N/A | |
| Peter Esq | ADC Therapeutics SA | 58 | |
| Timothy CPA | ADTRAN Inc | 48 | |
| Anirban Chakraborty | Comtech Telecommunications Corp | N/A | |
| Keith Atwell | ADTRAN Inc | N/A | |
| Kristen HarringtonSmith | ADC Therapeutics SA | 51 | |
| Mohamed MD | ADC Therapeutics SA | 60 | |
| Brian Duggan | Comtech Telecommunications Corp | 82 | |
| Eugenia Litz | ADC Therapeutics SA | N/A | |
| Nancy CPA | Comtech Telecommunications Corp | 64 | |
| Jay Wirts | Belden Inc | 54 | |
| Aaron CFA | Belden Inc | N/A | |
| Lisa Kallebo | ADC Therapeutics SA | N/A | |
| Christoph Glingener | ADTRAN Inc | 57 | |
| Donald JD | Comtech Telecommunications Corp | 57 | |
| Michael Bondi | Comtech Telecommunications Corp | 51 | |
| Joia Thompson | ADTRAN Inc | N/A | |
| John Ratigan | Comtech Telecommunications Corp | N/A | |
| David Ege | ADC Therapeutics SA | 51 | |
| Donald Walther | Comtech Telecommunications Corp | 55 | |
Management Performance
| Return On Equity | -0.0702 | |||
| Return On Asset | -0.0257 |
Innovid Corp Leadership Team
Elected by the shareholders, the Innovid Corp's board of directors comprises two types of representatives: Innovid Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innovid. The board's role is to monitor Innovid Corp's management team and ensure that shareholders' interests are well served. Innovid Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innovid Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tanya AndreevKaspin, Executive Officer | ||
| Tim Braz, VP Sales | ||
| Stephanie Geno, Chief Officer | ||
| Stephen Cook, General Counsel | ||
| Ken Markus, Chief Officer | ||
| John Williams, Head Relations | ||
| Pr Netter, CEO CoFounder | ||
| Michal Livny, Executive Resources | ||
| Alex Rowe, Senior Sales | ||
| Anthony Callini, Chief Officer | ||
| Dani Cushion, Chief Officer | ||
| David Helmreich, Chief Officer | ||
| Jeff Austin, Senior Operations | ||
| Kenneth Markus, Chief Officer | ||
| Liel Golan, Executive Operations | ||
| Yuval Pemper, Chief Officer | ||
| Sarah Ripmaster, Senior Accounts | ||
| Tal Chalozin, CoFounder CTO | ||
| Arik Shahar, VP Measurement | ||
| Guy Kuperman, Chief Officer |
Innovid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innovid Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0702 | |||
| Return On Asset | -0.0257 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 450.54 M | |||
| Shares Outstanding | 150.92 M | |||
| Shares Owned By Insiders | 7.27 % | |||
| Shares Owned By Institutions | 55.65 % | |||
| Number Of Shares Shorted | 3.46 M | |||
| Price To Earning | 23.87 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Innovid Stock
If you are still planning to invest in Innovid Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innovid Corp's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |